168 related articles for article (PubMed ID: 302045)
21. [Cellular immunity and measles virus in Van Bogaert's subacute sclerosing panencephalitis. Apropos of a case].
Bizouard P; Hervé P; Lonchamp D; Estavoyer JM; Lamit J; Raffi A
Pediatrie; 1973; 28(7):703-11. PubMed ID: 4803532
[No Abstract] [Full Text] [Related]
22. Synthesis of antibodies against measles virus and myelin by in vitro stimulated B-cells derived from patients with subacute sclerosing panencephalitis.
Wirguin I; Steinitz M; Sicsic C; Abramsky O; Brenner T
Immunol Lett; 1993 Sep; 38(1):55-8. PubMed ID: 7507883
[TBL] [Abstract][Full Text] [Related]
23. Immunological mechanisms controlling measles virus infection.
Cernescu C
Virologie; 1981; 32(1):41-55. PubMed ID: 6171091
[TBL] [Abstract][Full Text] [Related]
24. [Virus infection in the central nervous system: immunological abnormalities in SSPE].
Sato T; Anno M; Takeda K; Uchiyama T; Togashi T
No To Shinkei; 1983 May; 35(5):443-9. PubMed ID: 6414494
[No Abstract] [Full Text] [Related]
25. Cellular and humoral immunity in subacute sclerosing panencephalitis.
Dhib-Jalbut SS; Abdelnoor AM; Haddad FS
Infect Immun; 1981 Jul; 33(1):34-42. PubMed ID: 6973545
[TBL] [Abstract][Full Text] [Related]
26. Immune response in subacute sclerosing panencephalitis: reduced antibody response to the matrix protein of measles virus.
Wechsler SL; Weiner HL; Fields BN
J Immunol; 1979 Aug; 123(2):884-9. PubMed ID: 458157
[TBL] [Abstract][Full Text] [Related]
27. Cellular immunity in subacute sclerosing panencephalitis.
Valdimarsson H; Agnarsdottir G; Lachmann PJ
Proc R Soc Med; 1974 Nov; 67(11):1125-9. PubMed ID: 4548192
[No Abstract] [Full Text] [Related]
28. Subacute sclerosing panencephalitis and multiple sclerosis: in vitro measles immunity and sensitization to myelin basic protein.
Sheremata W; Sazant A; Watters G
Can Med Assoc J; 1978 Mar; 118(5):509-13. PubMed ID: 343902
[TBL] [Abstract][Full Text] [Related]
29. Complement-dependent cytotoxicity of sera obtained from subacute sclerosing panencephalitis patients.
Kuwajima S; Minagawa T; Fujii N; Iida H
Microbiol Immunol; 1978; 22(3):143-53. PubMed ID: 672673
[TBL] [Abstract][Full Text] [Related]
30. Spontaneous cytotoxicity against measles virus infected and K562 cells in normal subjects and subacute sclerosing panencephalitis.
Sanal O; Ustaçelebi S; Başaran M; Aysun S; Ersoy F; Berkel AI
Boll Ist Sieroter Milan; 1985; 64(5):400-3. PubMed ID: 4091977
[TBL] [Abstract][Full Text] [Related]
31. Immunologic injury in measles virus infection. III. Presence and characterization of human cytotoxic lymphocytes.
Perrin LH; Tishon A; Oldstone MB
J Immunol; 1977 Jan; 118(1):282-90. PubMed ID: 830751
[TBL] [Abstract][Full Text] [Related]
32. Lymphocyte subpopulations in blood and cerebrospinal fluid from patients with subacute sclerosing panencephalitis.
Marrosu MG; Cianchetti C; Tondi M; Ennas MG; Marrosu G; Murru MR; Manconi PE
Acta Neurol Scand; 1983 Jan; 67(1):55-63. PubMed ID: 6188314
[TBL] [Abstract][Full Text] [Related]
33. Immunological findings during an acute relapse of subacute sclerosing panencephalitis in a patient with an unusually prolonged disease course.
Ilonen J; Cantell K; Reunanen M; Panelius M; Ziola B; Lund G; Salmi A
J Clin Lab Immunol; 1987 Jan; 22(1):41-7. PubMed ID: 3560197
[TBL] [Abstract][Full Text] [Related]
34. Coincidental fluctuations of humoral immunity and clinical progression in a patient with subacute sclerosing panencephalitis.
Friis B; Bloch B; Faber V; Salmi A; Ziola B
J Neurol; 1985; 232(1):52-4. PubMed ID: 3158724
[TBL] [Abstract][Full Text] [Related]
35. Immunologic and virologic studies of measles inclusion body encephalitis in an immunosuppressed host: the relationship to subacute sclerosing panencephalitis.
Roos RP; Graves MC; Wollmann RL; Chilcote RR; Nixon J
Neurology; 1981 Oct; 31(10):1263-70. PubMed ID: 7202137
[TBL] [Abstract][Full Text] [Related]
36. Impaired delayed hypersensitivity in subacute sclerosing panencephalitis.
Klajman A; Sternbach M; Ranon L; Drucker M; Geminder D; Sadan N
Acta Paediatr Scand; 1973 Sep; 62(5):523-6. PubMed ID: 4585166
[No Abstract] [Full Text] [Related]
37. Protective effect of measles virus inoculation on subacute sclerosing panencephalitis virus-infected mice.
Ohuchi M; Ohuchi R; Mifune K
Microbiol Immunol; 1986; 30(3):203-11. PubMed ID: 2425226
[TBL] [Abstract][Full Text] [Related]
38. Plasma and spinal-fluid blocking factor in SSPE.
Sell KW; Thurman GB; Ahmed A; Strong DM
N Engl J Med; 1973 Jan; 288(4):215-6. PubMed ID: 4682238
[No Abstract] [Full Text] [Related]
39. [Analysis of the occurrence of measles virus antibodies in the serum, cerebrospinal fluid, saliva and urine of children with subacute sclerosing panencephalitis (SSPE)].
Jankowski M; Gut W; Karkowska B
Med Dosw Mikrobiol; 1986; 38(2):114-9. PubMed ID: 3736275
[No Abstract] [Full Text] [Related]
40. Subacute sclerosing panencephalitis mortality, United States, 1979-2016: Vaccine-induced declines in SSPE deaths.
Pallivathucal LB; Noymer A
Vaccine; 2018 Aug; 36(35):5222-5225. PubMed ID: 30057285
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
